Nationaal Pijncongres Ing. Maurice Uytdewilligen (Bsc) Directeur APS-Therapy BV

Transcription

1 Nationaal Pijncongres 0 Ing. Maurice Uytdewilligen (Bsc) Directeur APS-Therapy BV

2 Disclosure belangen spreker (potentiële) belangenverstrengeling Voor bijeenkomst mogelijk relevante relaties met bedrijven Sponsoring of onderzoeksgeld Honorarium of andere (financiële) vergoeding Aandeelhouder Andere relatie, namelijk Geen Geen APS Therapy Geen Zie onder Bedrijfsnamen

3 Programma Deel : Theorie APS Therapy Deel : Workshop

4 Het ontstaan van APS Therapy APS Therapy is ontstaan in de begin jaren 0. De afkorting APS staat voor Actie Potentiaal Simulatie. Wordt veel gebruikt bij: - (Chronische) pijngerelateerde klachten. - Energie-gerelateerde klachten. - Sportblessures.

5 Microcurrent APS Therapy valt onder de Microcurrent behandelingen. Behandelbereik 0 00 µa. Cheng, et al () 00 µa -> 00% toename ATP ma -> afname ATP. Lage stroom intensiteit bevordert herstel. Hoge stroom intensiteit vertraagt herstel.

6 Microcurrent APS Therapy: - Simuleert de lichaamseigen Actie Potentiaal. - Verbetert de communicatie in de zenuwvezel. - Verhoogt de ATP (energie) in de cel. - Behandelt locaties en géén ziekten. - Versterkt herstelvermogen. - Stimuleert opname van medicatie door DC (iontoforese).

7 Prof. Chris Bernard

8 Bron: Research

9 Research

10 Research

11 Research

12 Grünenthal award project video

13 0 0 Before After Research Action Potential Simulation (APS) Therapy for pain in people with MS; report on a two year pilot study Emma Matthews RGN BSc, Queen s Nurse, Miranda Olding RGN MSCN, Heather Raisin, Emma Burgess, Rose Olding Beds & Northants MS Therapy Centre, Bedford, UK, Northampton Hospital NHS Trust, Northampton, UK. University of Hertfordshire, Hatfield, UK Northampton Hospital NHS Trust Introduction People with MS commonly suffer from pain. Overall prevalence is %, and up to 0% experience significant pain during the disease course. Neuropathic pain in particular is often resistant to treatment, or hard to resolve due to the unwanted side-effects of most of the appropriate drugs. Electrotherapies can contribute to the management of pain in MS. Results People whose pain was reduced. n:0 Pain reduced: (%) Sample results by pain area Joint pain and injury - usual level Discussion participants were able to reduce or withdraw from analgesic medication as a result of APS Therapy treatment, resulting in improved wellbeing. participants (not necessarily the same ones!), predominately with neuropathic pain, needed long term treatment to retain benefits, and have gone on to maintenance therapy, once a week. We heard of some exceptional case-studies using the micro-current Action Potential Simulation (APS) Therapy in MS. APS Therapy simulates the discharge of electricity along a cell, known as an action potential for therapeutic effect, primarily pain relief. Despite literature review of over 0 papers showing promise in pain relief and enhanced healing by micro-current, published research on APS Therapy for pain in MS was not available; for this reason, this study was carried out. Methods People who presented in the MS nurse s clinic with pain were screened for suitability and offered the chance to participate in an week trial. This involved using an APS Therapy micro-current machine, x a week, for x back to back minute electrode placements. (=0 mins approx) After teaching, around 0% were self-managing, and 0% of people required full assistance; this was given by volunteers, staff, or their informal carers. Pain was measured used the Visual Analogue Scale (VAS) for usual and worst level, prior, and at week. In year, we added the Brief Pain Inventory (BPI) and Pittsburgh Sleep Inventory, however, this study only examines data kept for the duration. 0 people began the study, and 0 went on to complete, treating different pains. From this sample, were women, and men. The average age was for women, for men. people had relapsing-remitting MS, 0 had a progressive form, and did not have MS. Pain not reduced: %) Pains that were reduced - usual level n: Pain reduced: (0%) Pain not reduced: 0%) Average reduction in pain Usual Pain Mean average VAS Before:. After:. Mean reduction:. Before After Worst Pain Mean average VAS Before:.0 After:. Mean reduction:. Before After N:. Mean VAS before:. (SD =.), Mean VAS after:. (SD =.0). t() =., p=0.00, two-tailed Neuropathic pain in feet and legs - usual level Before After N:. Mean VAS before:.0 (SD =.) Mean VAS after:. (SD =.). t() =.0, p=0.00, two-tailed. Other neuropathic pains - usual level N:. Mean VAS before:. (SD =.) Before After Mean VAS after:. (SD =.) t() =.0, p=0.00, two-tailed. Back pain - usual level N;. Mean VAS before:.0 (SD =.) Before After Mean VAS after:. (SD =.). t() =., p=0.00, Volunteers supported people to use APS Therapy There were many self-reported other benefits that were perceived to result from the therapy, which we had not initially kept outcome measures for. In order of incidence of reporting, benefits were: Usual pains with final score of 0 on VAS Worst pains with final score of 0 on VAS For this exploratory pilot study, there was no control group, and many possible variables. Data was collected in the working clinic, by staff and clinicians, which can introduce bias to the results. The introduction of other new therapies or treatments (eg physiotherapy, medication changes) was avoided where possible during the trial period, (except for the reduction or withdrawal of analgesics), but not banned. The mode of action of APS Therapy is not fully understood. It has been postulated that by applying external action potentials, the removal of inflammatory products is assisted, providing relief of nociceptive pain. Considering neuropathic pain, release of neurotransmitters is known to be stimulated by the electrical discharge of action potentials along nerve cells, and voltage gated ion channels remain a key target for pharmaceuticals. In MS, the normal conduction of action potentials is detrimentally affected by the loss of myelin. APS Therapy replicates the passage of action potentials; this may explain why some people with MS experience particular benefits. Conclusion APS Therapy seemed to be a safe and effective therapy to try in cases of both neuropathic and nociceptive pain. Statistical testing proposed effectiveness in all but the smallest sample ( other nociceptive pain ) Participants in this study, most of whom had MS, had a significant reduction in pain using APS Therapy in % of cases. The therapy was safe, and in the main, people were extremely happy with this mode of treatment, preferring it to drug therapy, and in some cases reducing and discontinuing analgesic drugs as a result. We hope that by presenting our pilot study of an APS Therapy service in the context of available research on the subject, we can stimulate further, robust clinical research, and practical use..foley, P.L, et al. Prevalence and natural history of pain in adults with multiple sclerosis: systematic review and meta-analysis. Pain 0: () :-.. Ehde DM, et al. The scope and nature of pain in persons with multiple sclerosis.multiple Sclerosis. 00;(): -.. Hirsh AT, et al. Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors. Archives of Physical Medicine and Rehabilitation 00;0(): -.. Van der Plaat L. APS Therapy Case Studies ( Unpublished) 0. Poltawski L, Watson T. Bioelectricity and microcurrent therapy for tissue healing. 00 Physical Therapy Reviews : ;0-. Van Papendorp D, Kruger M, Maritz C, Dipenaar N. Action potential simulation therapy: Self assessment by patients with chronic pain. 000 Geneeskunde Med J : - Pain free (%) Pain free (0%) Acknowledgements & Disclosures Beds & Northants MS Therapy Centre and all the APS Therapy clinic volunteers for their support and hard work. MS Therapy Centres national & CMSC for assistance to exhibit at CMSC conference. Since completion of this study, Miranda Olding now also works for to train and distribute APS Therapy in the UK.

14 APS bij MS Centre UK

15 Workshop

16 Behandelschema

17 Vragen?